We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Gait Speed for Predicting Cardiovascular Events After Myocardial Infarction

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01484158
First Posted: December 2, 2011
Last Update Posted: January 22, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Yasushi Matsuzawa, Yokohama City University Medical Center
November 30, 2011
December 2, 2011
January 22, 2015
October 2001
December 2012   (Final data collection date for primary outcome measure)
Cardiovascular Events [ Time Frame: 5 years ]
cardiovascular death, non-fatal myocardial infarction and non-fatal stroke
Same as current
Complete list of historical versions of study NCT01484158 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Gait Speed for Predicting Cardiovascular Events After Myocardial Infarction
Gait Speed for Predicting Cardiovascular Events After Myocardial Infarction
There are growing evidences that gait speed is inversely associated with all causes mortality especially cardiovascular mortality among the elderly. The purpose of this study is to evaluate the predictive value of gait speed for cardiovascular events in patients after ST-segment elevation myocardial infarction (STEMI).
The investigators will enroll patients capable of walking with STEMI. All patients will receive successful reperfusion therapy within 12-hour from onset. Gait speed during cardiac rehabilitation is measured. Cardiovascular events were defined as a composite of cardiovascular death, non-fatal myocardial infarction and non-fatal stroke, for an average follow-up period.
Observational
Observational Model: Case-Only
Time Perspective: Prospective
Not Provided
Retention:   Samples Without DNA
Description:
We retain only blood sample only in this study.
Probability Sample
Patients with acute myocardial infarction.
Myocardial Infarction
Not Provided
Myocardial Infarction
Patients with myocardial infarction
Matsuzawa Y, Konishi M, Akiyama E, Suzuki H, Nakayama N, Kiyokuni M, Sumita S, Ebina T, Kosuge M, Hibi K, Tsukahara K, Iwahashi N, Endo M, Maejima N, Saka K, Hashiba K, Okada K, Taguri M, Morita S, Sugiyama S, Ogawa H, Sashika H, Umemura S, Kimura K. Association between gait speed as a measure of frailty and risk of cardiovascular events after myocardial infarction. J Am Coll Cardiol. 2013 May 14;61(19):1964-72. doi: 10.1016/j.jacc.2013.02.020. Epub 2013 Mar 14.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
450
December 2012
December 2012   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Clinical diagnosis of ST-segment elevation acute myocardial infarction
  • Must be treated within 12 hours after symptom onset
  • Must be able to walk
  • Must receive successful primary percutaneous coronary intervention

Exclusion Criteria:

  • History of prior myocardial infarction
  • Cerebrovascular disease with residual hemiplegia
  • Severe peripheral arterial disease
Sexes Eligible for Study: All
30 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Not Provided
 
 
NCT01484158
Gait Speed Outcome Study
No
Not Provided
Not Provided
Yasushi Matsuzawa, Yokohama City University Medical Center
Yokohama City University Medical Center
Not Provided
Not Provided
Yokohama City University Medical Center
January 2015
To Top